George Freeman

Role, work or services: Chairman of Advisory Board, Nodenza Venture Partners From: 20 May 2024. Payer: Nodenza Venture Partners (Nodenza Venture Partners is a venture capital firm specialising in biotechnology and medical device investments.), 228 Park Avenue South, PMB 67135, New York, NY, 10003-1502, United States ACOBA consulted: Yes

Role, work or services: Science and Technology Advisor, The Pioneer Group From: 22 May 2024. Payer: Pioneer Group Limited (Pioneer is a private property management company that provides venture building, incubation, and venture investment support to early stage companies, as well as the development and operation of life science incubator facilities.), New Derwent House, 69-73 Theobalds Road, London WC1X 8TA ACOBA consulted: Yes

Role, work or services: Advisor From: 16 October 2024. Payer: Nighthawk Partners Limited (Nighthawk Partners Limited gives eligible, UK SME’s instant access to working capital that is being used for Innovation, UK and International Commercialisation. The company’s mission is to incentivise UK SMEs to succeed even when their working capital has been adversely impacted by tough economic times.), 2 Catherine Place London, SW1E 6HF United Kingdom ACOBA consulted: Yes

Role, work or services: Advisory Board, Science, Innovation and Technology From: 1 December 2024. Payer: Space 4 Earth VC Fund (S4E VC Fund is being set up as a new Fund focused on investing in space related technologies which promote: efficient and sustainable production of food, clean water for everyone, decarbonisation, and the end to deforestation. The Fund does not have a relationship with the government. The fund will be a standard GP/LP fund structure, with the investment advisor and the advisory board based in the UK. The General Partner could be located in the Channel Islands depending on requirements by investors, however the core of the Fund and its Fund Manager and advisory board will be in the UK.), 4 Cavendish Square, London, W1G 0PG ACOBA consulted: Yes

Role, work or services: Advisor to the Board of Trustees From: 14 February 2025. Payer: The Guy Foundation Family Trust (A UK-based charitable foundation established in 2018 to facilitate thinking and research on the role of quantum mechanics and thermodynamics in living systems, with the ultimate goal of using this understanding to advance healthcare. The Foundation has not previously received government funding.), The Estate Office, Chedington Court, Chedington, Beaminster DT8 3HY ACOBA consulted: Yes

Role, work or services: Speaker at the Oxford Global CEO Programme 2025 (in Hong Kong and Singapore) From: 5 December 2025. Until: 12 December 2025. Payer: Oxford Institute of Digital Health, Radcliffe Primary Care Building, Radcliffe Observatory Quarter, Woodstock Road, Oxford, OX2 6GG

Dates of visit: 5 December 2025 to 12 December 2025 Purpose of visit: Speaking at the Oxford Global CEO Programme 2025 in Hong Kong and Singapore. ( A speakers fee of £5000 has been registered under Category 1.)

Dates of visit: 23 October 2025 to 23 October 2025 Purpose of visit: LPEA Insights Conference 2025 in Luxembourg.

Dates of visit: 28 October 2025 to 29 October 2025 Purpose of visit: Participation as a speaker at the ESPI Conference in Vienna.

Dates of visit: 5 November 2025 to 12 November 2025 Purpose of visit: Global Networking Event

Donor status: individual

Member of Science Superpower Steering Group at UK Onward, an independent, not-for-profit Think Tank. I consulted ACOBA about this unpaid role. Date interest arose: 26 April 2024

Unpaid Director of Regeneration Theatre Company, a not-for-profit outreach theatre company founded by me and my wife, a professional theatre director, in conjunction with the National Youth Arts Trust (Reg Charity No:1152367). The theatre company is funded by philanthropic donors through the National Youth Arts Trust. Date interest arose: 1 September 2024 Date interest ended: 1 January 2026

In my capacity as a Norfolk MP, I am a trustee for Aviornis UK – a Rare Birds Breeds Charity. This is an unpaid role. Date interest arose: 2 April 2023

Voluntary Advisory Council Member of the Centre for Long Term Resilience. I consulted ACOBA about this unpaid role. Date interest arose: 6 May 2024

Strategic Adviser at The Centre for MC, a not for profit industry membership organisation focused on clinical research and development of cannabinoid pharmaceuticals and healthcare products. I consulted ACOBA about this role; it is currently unpaid. Date interest arose: 6 April 2024

Nature of business: RAL is a limited company which I originally set up (after leaving Government in 2020) as an advisory business to support regeneration projects across the UK to harness innovation led growth to drive inward investment and regeneration. Held jointly with or on behalf of: Wife Interest held: from 8 October 2024